Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2015

Open Access 01-12-2015 | Study protocol

Use of moxibustion to treat primary dysmenorrhea at two interventional times: study protocol for a randomized controlled trial

Authors: Jie Yang, Siyi Yu, Lixing Lao, Mingxiao Yang, JianPing Chen, Xiao Luo, Yongxia Wang, Xiangzhu Chen, Juan Li, Lihua Zhu, Qianhua Zheng, Youping Hu, Xi Wu, Fanrong Liang

Published in: Trials | Issue 1/2015

Login to get access

Abstract

Background

Dysmenorrhea is a common menstrual complaint among adolescent girls and women of reproductive age. The treatment of dysmenorrhea is typically selected from multidisciplinary options, including complementary and alternative medicine such as acupuncture and moxibustion. However, there are few published randomized controlled trials concerning moxibustion treatment for dysmenorrhea. This trial aims to investigate the efficacy and safety of moxibustion for primary dysmenorrhea, and to identify the optimal time of moxibustion treatment for primary dysmenorrhea.

Methods/Design

This protocol is for a randomized controlled trial in which the assessor and statistician will be blinded. A total of 222 eligible patients with dysmenorrhea will be randomly assigned to three groups in a 1:1:1 ratio as treatment group A (treated before menstruation onset), treatment group B (treated at the onset of menstruation), or control group C (waiting list group). The participants assigned to the treatment groups will receive suspended moxibustion treatment at Sanyinjiao (SP6) and Guanyuan (CV4), while the waiting list group will not receive moxibustion treatment until the completion of the study. The trial period will consist of three baseline menstrual cycles, three menstrual cycles of treatment, and three menstrual cycles in the follow-up period. The primary outcome will be measured by changes in the Cox Menstrual Symptom Scale and the secondary outcomes will be measured using the Visual Analogue Scale, Cox Retrospective Symptom Scale, diary entries, the Self-rating Depression Scale, and the Self-rating Anxiety Scale. The safety of moxibustion will be assessed at every visit.

Discussion

This trial aims to assess the effectiveness and safety of moxibustion for primary dysmenorrhea, as well as to determine whether the optimal time of treatment for primary dysmenorrhea in clinical practice is before or after the onset of menstrual pain.

Trial registration

Chinese Clinical Trial Register: ChiCTR-TRC-14004627, registered on 9 May 2014.
Literature
1.
2.
Patel V, Tanksale V, Sahasrabhojanee M, Gupte S, Nevrekar P. The burden and determinants of dysmenorrhoea: a population‐based survey of 2262 women in Goa. India Br J Obstet Gynaecol. 2006;113(4):453–63.CrossRef
3.
Ju H, Jones M, Mishra G. The prevalence and risk factors of dysmenorrhea. Epidemiol Rev. 2014;36(1):104–13.CrossRefPubMed
4.
Burnett MA, Antao V, Black A, Feldman K, Grenville A. Lea R: Prevalence of primary dysmenorrhea in Canada. J Obstet Gynaecol Can. 2005;27(8):765–70.CrossRefPubMed
5.
6.
Weissman AM, Hartz AJ, Hansen MD. Johnson SR: The natural history of primary dysmenorrhoea: a longitudinal study. Br J Obstet Gynaecol. 2004;111(4):345–52.CrossRef
7.
Hillen TI, Grbavac SL, Johnston PJ, Straton JA, Keogh JM. Primary dysmenorrhea in young Western Australian women: prevalence, impact, and knowledge of treatment. J Adolesc Health. 1999;25(1):40–5.CrossRefPubMed
8.
Wilson CA, Keye Jr WR. A survey of adolescent dysmenorrhea and premenstrual symptom frequency: a model program for prevention, detection and treatment. J Adolesc Health Care. 1989;10(4):317–22.CrossRefPubMed
9.
Zhang W. Li Wan Po A. Efficacy of minor analgesics in primary dysmenorrhoea: a systematic review Br J Obstet Gynaecol. 1998;105(7):780–9.PubMed
10.
Morrison JC, Ling FW, Forman EK, Bates GW, Blake PG. Vecchio TJ: Analgesic efficacy of ibuprofen for treatment of primary dysmenorrhea. South Med J. 1980;73(8):999–1002.CrossRefPubMed
11.
Yang H, Liu CZ, Chen X, Ma LX, Xie JP, Guo NN. Systematic review of clinical trials of acupuncture‐related therapies for primary dysmenorrhea. Acta Obstet Gynecol Scand. 2008;87(11):1114–22.CrossRefPubMed
12.
Lavender T, Hofmeyr GJ, Neilson JP, Kingdon C, Gyte GM. Caesarean section for non-medical reasons at term. Cochrane Database Syst Rev. 2012;14(3), CD004660.
13.
World Health Organization. WHO international standard terminologies on traditional medicine in the western pacific region. Western Pacific Region: World Health Organization; 2007.
14.
Jianhua C. Abdominal acupuncture combined with moxibustion for pelvic inflammation. J Acupunct Tuina Sci. 2011;9(5):301–3.CrossRef
15.
Zhang J-F, Wu Y-C. Modern progress of mechanism of moxibustion therapy. J Acupunct Tuina Sci. 2006;4(5):257–60.CrossRef
16.
Li W, Liu L, Sun L. Analysis on therapeutic effect of substance-partitioned moxibustion at Guanyuan (CV 4) and shenque (CV 8) for treatment of primary dysmenorrhea of cold-damp type. Zhongguo Zhen Jiu. 2006;26(7):481–2.PubMed
17.
Yang X, Liu J. Application of fuzzy comprehensive evaluation technique in CAPP. Mach Tool Hydraulics. 2009;2(051):153–5.
18.
Lee D-H, Kim J-I, Lee MS, Choi T-Y, Choi S-M, Ernst E. Moxibustion for ulcerative colitis: a systematic review and meta-analysis. BMC Gastroenterol. 2010;10(1):36.CrossRefPubMedPubMedCentral
19.
Lee MS, Shin B-C, Kim J-I, et al. Moxibustion for stroke rehabilitation systematic review. Stroke. 2010;41(4):817–20.CrossRefPubMed
20.
Park J-E, Lee M, Jung S, Kim A, Kang K, Choi J. Moxibustion for treating menopausal hot flashes: a randomized clinical trial. Menopause. 2009;16(4):660–5.CrossRefPubMed
21.
Lee MS, Choi T-Y, Park J-E. Han C-h, Ernst E: Effects of moxibustion for constipation treatment: a systematic review of randomized controlled trials. Chinese Med. 2010;5(1):28.CrossRef
22.
23.
Okazaki M, Aizawa S, Yamauchi M, Oguchi K. Effects of single moxibustion on cutaneous blood vessel and microvascular permeability in mice. Am J Chin Med. 1990;18(03n04):121–30.CrossRefPubMed
24.
Ma Y-X, Ye X-N, Liu C-Z, Cai P-Y, Li Z-F. Du D-Q:A clinical trial of acupuncture about time-varying treatment and points selection in primary dysmenorrhea. J Ethnopharmacol. 2013;148(2):498–504.CrossRefPubMed
25.
Lefebvre G, Pinsonneault O, Antao V, Black A, Burnett M. Feldman K,: Primary dysmenorrhea consensus guideline. J Obstet Gynaecol Can. 2005;27(12):1117–46.CrossRefPubMed
26.
Zhu X, Bensoussan A, Zhu L, Qian J, Xu M, Zhou C. Primary dysmenorrhoea: A comparative study on Australian and Chinese women. Complement Ther Med. 2009;17(3):155–60.CrossRefPubMed
27.
Zhi L. Randomized controlled study on the analgesic effect of superficial needling plus electrostimulation of sanyinjiao (SP6) for primary dysmenorrhea. Zhen Ci Yan Jiu. 2007;32(5):342.PubMed
28.
Cox DJ, Meyer RG. Behavioral treatment parameters with primary dysmenorrhea. J Behav Med. 1978;1(3):297–310.CrossRefPubMed
29.
Liu CZ, Xie JP, Wang LP, Zheng YY, Ma ZB. Yang H: Immediate analgesia effect of single point acupuncture in primary dysmenorrhea: a randomized controlled trial. Pain Med. 2011;12(2):300–7.CrossRefPubMed
30.
Zung WW, Richards CB, Short MJ. Self-rating depression scale in an outpatient clinic: further validation of the SDS. Arch Gen Psychiatry. 1965;13(6):508.CrossRefPubMed
31.
32.
Yang J, Chen J, Lao L, Yang M, Chen J, Bo L. Effectiveness study of moxibustion on pain relief in primary dysmenorrhea: study protocol of a randomized controlled trial. Evid Based Complement Alternat Med. 2014;2014:1–6.
33.
Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273(5):408–12.CrossRefPubMed
Metadata
Title
Use of moxibustion to treat primary dysmenorrhea at two interventional times: study protocol for a randomized controlled trial
Authors
Jie Yang
Siyi Yu
Lixing Lao
Mingxiao Yang
JianPing Chen
Xiao Luo
Yongxia Wang
Xiangzhu Chen
Juan Li
Lihua Zhu
Qianhua Zheng
Youping Hu
Xi Wu
Fanrong Liang
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Trials / Issue 1/2015
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-015-0552-1

Other articles of this Issue 1/2015

Trials 1/2015 Go to the issue

Study protocol

Evaluating processes of care and outcomes of children in hospital (EPOCH): study protocol for a randomized controlled trial

Research

Key stakeholder perceptions about consent to participate in acute illness research: a rapid, systematic review to inform epi/pandemic research preparedness

Study protocol

The Karnataka Anemia Project 2 — design and evaluation of a community-based parental intervention to improve childhood anemia cure rates: study protocol for a cluster randomized controlled trial

Study protocol

The effectiveness and cost-effectiveness of the peer-delivered Thinking Healthy Programme for perinatal depression in Pakistan and India: the SHARE study protocol for randomised controlled trials

Research

Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews

Study protocol

Effectiveness of prepregnancy care for women with pregestational diabetes mellitus: protocol for a systematic review of the literature and identification of a core outcomes set using a Delphi survey